At the National Headache Foundation, our mission is to create a world free of headache, and any associated pain and suffering. We work towards this vision through awareness, advocacy, education, and research. Under the research umbrella specifically, we support clinical research into potential headache causes...
A national survey of more than 3,900 individuals with migraine reflects the impact the disease has on their life beyond the pain and frustration of finding an effective treatment. Many respondents reported difficulty receiving a diagnosis when they were young and said they continued to feel stigmatized by their disease.
Results released at the end of August 2016 show that 61% of respondents began experiencing symptoms of migraine before the age of 19. However, only 26% were formally diagnosed before they were an adult.
Quality communication is critical between patients and health care professionals, but a new study has found that it often falls short between patients with chronic migraine and their physicians. This situation leads to suboptimal treatment, according to a new study that included 20 neurologists from around the country.
Migraineurs and those who suffer from cluster headaches may find relief from the pain with the help of a new procedure that uses lidocaine, a common topical anesthetic.
When evaluating the treatment, called image-guided, intranasal sphenopalatine ganglion (SPG) blocks, researchers inserted a spaghetti-sized catheter through the nasal passages of patients and administered 4% lidocaine to the sphenopalatine ganglion, a nerve bundle just behind the nose associated with migraines. This procedure was assisted with fluoroscopy, a type of imaging that could be compared to an X-ray movie.
According to a recent study, using a screening tool that asks if a patient experiences headache disability, nausea, and sensitivity to light can help diagnose migraine and decrease opiate prescriptions.